End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
16.67
CNY
|
+1.21%
|
|
-1.88%
|
+12.86%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
69,740
|
85,800
|
127,307
|
88,278
|
108,025
|
121,921
|
-
|
-
|
Enterprise Value (EV)
1 |
69,740
|
85,800
|
127,307
|
88,278
|
108,025
|
121,921
|
121,921
|
121,921
|
P/E ratio
|
18.3
x
|
18.6
x
|
17.9
x
|
14
x
|
19.2
x
|
14
x
|
8.61
x
|
8.26
x
|
Yield
|
-
|
2.39%
|
1.85%
|
1.16%
|
1.9%
|
2.73%
|
3.13%
|
4.5%
|
Capitalization / Revenue
|
5.14
x
|
5.39
x
|
5.46
x
|
3.11
x
|
3.71
x
|
3.07
x
|
2.13
x
|
1.98
x
|
EV / Revenue
|
5.14
x
|
5.39
x
|
5.46
x
|
3.11
x
|
3.71
x
|
3.07
x
|
2.13
x
|
1.98
x
|
EV / EBITDA
|
-
|
-
|
13.1
x
|
9.62
x
|
12.6
x
|
9.01
x
|
6
x
|
5.87
x
|
EV / FCF
|
-
|
-
|
113
x
|
-26.3
x
|
-26.2
x
|
46.6
x
|
6.82
x
|
7.78
x
|
FCF Yield
|
-
|
-
|
0.89%
|
-3.8%
|
-3.82%
|
2.15%
|
14.7%
|
12.9%
|
Price to Book
|
2.99
x
|
3.31
x
|
4.15
x
|
2.61
x
|
2.81
x
|
2.69
x
|
2.08
x
|
1.82
x
|
Nbr of stocks (in thousands)
|
7,333,360
|
7,333,360
|
7,333,360
|
7,313,816
|
7,313,816
|
7,313,816
|
-
|
-
|
Reference price
2 |
9.510
|
11.70
|
17.36
|
12.07
|
14.77
|
16.67
|
16.67
|
16.67
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
13,568
|
15,928
|
23,300
|
28,430
|
29,136
|
39,735
|
57,193
|
61,688
|
EBITDA
1 |
-
|
-
|
9,738
|
9,174
|
8,600
|
13,529
|
20,305
|
20,774
|
EBIT
1 |
4,632
|
5,536
|
8,421
|
7,720
|
6,786
|
10,460
|
16,756
|
17,556
|
Operating Margin
|
34.14%
|
34.76%
|
36.14%
|
27.15%
|
23.29%
|
26.32%
|
29.3%
|
28.46%
|
Earnings before Tax (EBT)
1 |
-
|
5,249
|
8,121
|
7,307
|
6,467
|
10,108
|
16,444
|
17,204
|
Net income
1 |
3,802
|
4,623
|
7,070
|
6,303
|
5,651
|
8,757
|
14,197
|
14,820
|
Net margin
|
28.02%
|
29.02%
|
30.35%
|
22.17%
|
19.39%
|
22.04%
|
24.82%
|
24.02%
|
EPS
2 |
0.5184
|
0.6300
|
0.9700
|
0.8600
|
0.7700
|
1.194
|
1.937
|
2.018
|
Free Cash Flow
1 |
-
|
-
|
1,131
|
-3,351
|
-4,129
|
2,619
|
17,877
|
15,669
|
FCF margin
|
-
|
-
|
4.85%
|
-11.79%
|
-14.17%
|
6.59%
|
31.26%
|
25.4%
|
FCF Conversion (EBITDA)
|
-
|
-
|
11.61%
|
-
|
-
|
19.36%
|
88.04%
|
75.43%
|
FCF Conversion (Net income)
|
-
|
-
|
15.99%
|
-
|
-
|
29.91%
|
125.92%
|
105.73%
|
Dividend per Share
2 |
-
|
0.2800
|
0.3210
|
0.1400
|
0.2800
|
0.4550
|
0.5220
|
0.7500
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,131
|
-3,351
|
-4,129
|
2,619
|
17,877
|
15,669
|
ROE (net income / shareholders' equity)
|
19.3%
|
19%
|
25%
|
19.6%
|
15.7%
|
19.3%
|
24.6%
|
22.2%
|
ROA (Net income/ Total Assets)
|
12.6%
|
12.9%
|
17.1%
|
12.4%
|
8.75%
|
11.5%
|
15%
|
14.5%
|
Assets
1 |
30,061
|
35,700
|
41,239
|
50,976
|
64,604
|
76,256
|
94,605
|
102,206
|
Book Value Per Share
2 |
3.180
|
3.530
|
4.180
|
4.620
|
5.260
|
6.190
|
8.010
|
9.140
|
Cash Flow per Share
2 |
0.4900
|
0.7100
|
0.8900
|
0.9000
|
1.190
|
1.700
|
2.760
|
2.390
|
Capex
1 |
4,541
|
2,574
|
5,357
|
9,977
|
12,822
|
5,314
|
4,633
|
3,827
|
Capex / Sales
|
33.46%
|
16.16%
|
22.99%
|
35.09%
|
44.01%
|
13.37%
|
8.1%
|
6.2%
|
Announcement Date
|
3/15/20
|
3/4/21
|
3/8/22
|
3/9/23
|
3/21/24
|
-
|
-
|
-
|
Last Close Price
16.67
CNY Average target price
20.74
CNY Spread / Average Target +24.42% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.86% | 16.83B | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +7.73% | 15.03B | | +16.93% | 14.96B | | -16.39% | 13.52B |
Other Commodity Chemicals
|